SCHEMBL28028854

SCHEMBL28028854

OCC(c1ccccc1)c1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
TDO2 P48775 2/20 0.47
GAA P10253 1/20 0.46
CYP19A1 P11511 1/20 0.44
CNR2 P34972 1/20 0.41
HRH1 P35367 3/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
HTR2A P28223 3/20 0.39
TRPA1 O75762 2/20 0.38
TAAR1 Q96RJ0 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP3A4 P08684 1/20 0.36
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23159325 0.81 HRH1 (0.50) IDO1TDO2GAACYP19A1CNR2
SCHEMBL26693459 0.81 HRH1 (0.50) IDO1TDO2GAACYP19A1CNR2
SCHEMBL14672470 0.79 PRKCA (0.51) GAATAAR1
SCHEMBL3910983 0.79 TAAR1 (0.60) IDO1TDO2GAACYP19A1HRH1
SCHEMBL17802353 0.77 IDO1 (0.42) IDO1TDO2GAACYP19A1CNR2
SCHEMBL9326756 0.77 HPGD (0.50) HRH1OPRK1HTR2ATRPA1TAAR1
SCHEMBL193835 0.77 HTR2A (0.52) HRH1HTR2ATRPA1TAAR1TDP1
SCHEMBL11085997 0.76 GAA (0.47) IDO1TDO2GAACYP19A1CNR2
SCHEMBL777640 0.76 SRC (0.46) IDO1TDO2GAACYP19A1CNR2
SCHEMBL24877434 0.76 CES2 (0.42) IDO1TDO2GAACNR2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104781256-B 3,4 pairs of substitution oxazolidinone derivatives and its purposes as the inhibitor of calcium-activated potassium channel 霍夫曼-拉罗奇有限公司 2017-09-29 CN disclosed
CN-104781256-A 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel HOFFMANN LA ROCHE 2015-07-15 CN disclosed